News Alkem Laboratories Limited

Equities

ALKEM

INE540L01014

Market Closed - NSE India S.E. Other stock markets 07:43:47 2024-04-19 am EDT			5-day change	1st Jan Change
4,616 ^INR	-0.74%		-2.51%	-11.27%

Mar. 28	Alkem Laboratories Forms Subsidiary for Medical Devices Business	MT
Mar. 28	Alkem Laboratories Limited Announces Incorporation of Subsidiary Alkem Medtech Private Limited	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alkem Laboratories Forms Subsidiary for Medical Devices Business	Mar. 28	MT
Alkem Laboratories Limited Announces Incorporation of Subsidiary Alkem Medtech Private Limited	Mar. 28	CI
Alkem Laboratories Gets 10 Observations from US FDA After Baddi, India Unit Inspection	Mar. 27	MT
Norway's Biosergen Secures Indian Regulatory Approval for Clinical Trial of Fungal Infections Therapy	Feb. 12	MT
Biosergen receives regulatory approval to test lead candidate BSG005 in patients with invasive fungal infection.	Feb. 12	AQ
Jefferies Adjusts Alkem Laboratories’ Price Target to INR4,470 From INR3,960, Keeps at Underperform	Feb. 12	MT
Transcript : Alkem Laboratories Limited, Q3 2024 Earnings Call, Feb 09, 2024	Feb. 09
Alkem Laboratories Limited Approves Interim Dividend for Financial Year 2023-24 , Payable on 1 March, 2024	Feb. 09	CI
Alkem Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 09	CI
Research Update Biosergen: Licensing deal with Alkem and CTA submission	Jan. 16	AQ
Indian Equities Close Higher on Friday, Lifted by IT Stocks	Jan. 12	MT
Alkem Laboratories Names Successor to Outgoing CFO	Jan. 12	MT
Alkem Laboratories Limited Announces CFO Changes	Jan. 12	CI
Heritage Global, Investors Acquire Pharmaceutical Plant from Alkem Laboratories	Jan. 11	MT
Federal Machinery & Equipment Co., Heritage Global Partners, Inc., New Mill Capital LLC, Keith Machinery Corp acquired Pharmaceutical Site in Fenton Missouri from Alkem Laboratories Limited.	Jan. 10	CI
Alkem Laboratories Limited Appoints Ashish Sehgal to Hold Senior Management Position in the Company Effective 15 December 2023	Dec. 15	CI
Biosergen's Partner Alkem Laboratories Submits Clinical Trial Application for First Patient Study with BSG005 in Invasive Fungal Infections in India as a Rescue Therapy	Dec. 12	AQ
Alkem Laboratories Limited Submits Clinical Trial Application to Central Drugs Standard Control Organization in India	Dec. 12	CI
Alkem Laboratories Limited Submits Clinical Trial Application for First Patient Study with Bsg005 in Invasive Fungal Infections in India as A Rescue Therapy	Dec. 12	CI
Biosergen's Indian Partner Seeks Approval for Clinical Trial of Antifungal Drug Candidate	Dec. 12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Alkem Laboratories Limited

Equities

ALKEM

INE540L01014

Summary

Filters